These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 27319187)
1. [Programs for Continuing Medical Education: A session; 1. New therapeutic strategies for hepatitis C by direct-acting antivirals (DAA)]. Sakamoto N Nihon Naika Gakkai Zasshi; 2016 Mar; 105(3):424-8. PubMed ID: 27319187 [No Abstract] [Full Text] [Related]
2. Does HIV Influence Hepatitis C Cure Rates Using Direct-Acting Antivirals? de Mendoza C AIDS Rev; 2016; 18(2):112-3. PubMed ID: 27232507 [TBL] [Abstract][Full Text] [Related]
3. Effectiveness and cost of hepatitis C virus cryoglobulinaemia vasculitis treatment: From interferon-based to direct-acting antivirals era. Cacoub P; Vautier M; Desbois AC; Lafuma A; Saadoun D Liver Int; 2017 Dec; 37(12):1805-1813. PubMed ID: 28467688 [TBL] [Abstract][Full Text] [Related]
4. Treatment of acute hepatitis C: recommendations from an expert panel of the Italian Society of Infectious and Tropical Diseases. Gaeta GB; Puoti M; Coppola N; Santantonio T; Bruno R; Chirianni A; Galli M Infection; 2018 Apr; 46(2):183-188. PubMed ID: 29238918 [TBL] [Abstract][Full Text] [Related]
5. Drug interactions of hepatitis C direct-acting antivirals in the HIV-infected person. El-Sherif O; Back D Curr HIV/AIDS Rep; 2015 Sep; 12(3):336-43. PubMed ID: 26159742 [TBL] [Abstract][Full Text] [Related]
6. [Predictive factors of response to Direct Acting Antivirals therapy Drug resistance hepatitis C virus]. Suda G; Yamasaki K; Sakamoto N Nihon Rinsho; 2015 Dec; 73 Suppl 9():189-92. PubMed ID: 26845928 [No Abstract] [Full Text] [Related]
7. Value and innovation of direct-acting antivirals: long-term health outcomes of the strategic plan for the management of hepatitis C in Spain. Turnes J; Domínguez-Hernández R; Casado MÁ Rev Esp Enferm Dig; 2017 Dec; 109(12):809-817. PubMed ID: 29152988 [TBL] [Abstract][Full Text] [Related]
8. Concomitant use of direct-acting antivirals and chemotherapy in hepatitis C virus-infected patients with cancer. Economides MP; Mahale P; Kyvernitakis A; Turturro F; Kantarjian H; Naing A; Hosry J; Shigle TL; Kaseb A; Torres HA Aliment Pharmacol Ther; 2016 Dec; 44(11-12):1235-1241. PubMed ID: 27730654 [TBL] [Abstract][Full Text] [Related]
9. Antiviral therapies for managing viral hepatitis in lymphoma patients. Merli M; Rattotti S; Gotti M; Arcaini L Expert Opin Pharmacother; 2017 Mar; 18(4):363-376. PubMed ID: 28140702 [TBL] [Abstract][Full Text] [Related]
10. The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C-infected patients treated with direct-acting antivirals with and without pegylated interferon: A Belgian experience. Bielen R; Moreno C; Van Vlierberghe H; Bourgeois S; Mulkay JP; Vanwolleghem T; Verlinden W; Brixco C; Decaestecker J; de Galocsy C; Janssens F; Van Overbeke L; Van Steenkiste C; D'Heygere F; Cool M; Wuyckens K; Nevens F; Robaeys G J Viral Hepat; 2017 Nov; 24(11):976-981. PubMed ID: 28504854 [TBL] [Abstract][Full Text] [Related]
11. [Hepatitis B and C: From molecular virology to new antiviral therapies (part 1)]. Thimme R; Heim M; Baumert TF; Nassal M; Moradpour D Dtsch Med Wochenschr; 2014 Mar; 139(13):655-9. PubMed ID: 24648178 [No Abstract] [Full Text] [Related]
12. Hepatitis C Virus Therapy for Decompensated and Posttransplant Patients. Dailey F; Ayoub WS J Clin Gastroenterol; 2017 Mar; 51(3):215-222. PubMed ID: 28178089 [TBL] [Abstract][Full Text] [Related]
13. Management of drug interactions with direct-acting antivirals in Dutch HIV/hepatitis C virus-coinfected patients: adequate but not perfect. Smolders EJ; Smit C; de Kanter C; Dofferhoff A; Arends JE; Brinkman K; Rijnders B; van der Valk M; Reiss P; Burger DM; HIV Med; 2018 Mar; 19(3):216-226. PubMed ID: 29194939 [TBL] [Abstract][Full Text] [Related]
14. Hepatitis C: how has France limited the expenses related to new treatments? Mouterde AL; Bocquet F; Fusier I; Paubel P Expert Rev Pharmacoecon Outcomes Res; 2016 Dec; 16(6):655-657. PubMed ID: 27732130 [No Abstract] [Full Text] [Related]
15. Interferon-free strategies without a nucleoside/nucleotide analogue. Welzel TM; Zeuzem S Semin Liver Dis; 2014 Feb; 34(1):47-57. PubMed ID: 24782258 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of hepatitis B reactivation among 62,920 veterans treated with oral hepatitis C antivirals. Belperio PS; Shahoumian TA; Mole LA; Backus LI Hepatology; 2017 Jul; 66(1):27-36. PubMed ID: 28240789 [TBL] [Abstract][Full Text] [Related]
17. Hepatitis C Treatment Uptake by New Prescribers After the Introduction of Direct Acting Antivirals. Kapadia SN; Johnson P; Schackman BR; Bao Y J Gen Intern Med; 2020 Mar; 35(3):975-977. PubMed ID: 31325131 [No Abstract] [Full Text] [Related]